Remarkably, our results presented significant alterations between the CXCL5 concentration in stage IV/III + IV of CRC and healthy controls, and significant differences between all TNM stages, which may indicate its contribution to the development of tumor progression and distant metastasis. The gene discussed is CXCL5; the disease is colorectal carcinoma.